Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator

NCT06426407 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT06426407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06426407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Terminated
Start date
October 1, 2025
Completion date
February 1, 2026
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

shock, septic